Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Lung Eosinophils Play Protective and Beneficial Role

By LabMedica International staff writers
Posted on 08 Sep 2016
During allergic reactions such as asthma, the immune system does not work correctly and responds in an abnormal way to harmless allergens present in the environment such as pollen and dust mites.

In an asthmatic individual, the eosinophil cells which are a type of granulocytes that are produced in the bone marrow and which circulate in the body via the blood and are recruited to the lungs where they participate to the pathological manifestations associated with an asthmatic reaction.

An international team of scientists led by those at the University of Liege (Belgium) identified the existence of a sub-group of eosinophils called resident eosinophils which are present in the lungs of healthy individuals and which, unlike inflammatory eosinophils, play a regulatory and protective role while maintaining the balance of the immune system and preventing it from responding in an abnormal way such as observed during an asthma attack. More...
The discovery of these specific eosinophils offers promising therapeutic and prophylactic opportunities for the treatment and prevention of asthma.

The team discovered this sub-type of eosinophil in mice and subsequently in humans. In mice, the nucleus of these resident eosinophils appears as a ring shape or doughnut shape, which makes them easily distinguishable from the other inflammatory eosinophils. In humans, all eosinophils have the same morphology, which could explain why the sub-types have only just been discovered. The scientists have also demonstrated, in both mice and humans, that the resident eosinophils carry an identical marker on their surface, the protein L-selectin or CD62L, which means that they are easily distinguishable from inflammatory eosinophils. Cell phenotyping and cell sorting were performed on a FACSAria III (BD Biosciences, San Jose, CA, USA).

Fabrice Bureau, DVM, PhD, a professor and senior author of the study said, “In the future, the question is to know how to facilitate the production of resident eosinophils, rather than inflammatory eosinophils, in the bone marrow. Indeed, by acting at the top of the cascade, we will have new weapons for the prevention of inflammatory diseases such as allergies or autoimmune diseases.” The study was published on August 22, 2016, in The Journal of Clinical Investigation.

Related Links:
University of Liege
BD Biosciences

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Portable Electronic Pipette
Mini 96
Rapid Molecular Testing Device
FlashDetect Flash10
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The genomic test measures eight gene activities in a melanoma tumor and combines this data with patient factors like age and tumor thickness (Photo courtesy of 123RF)

Genomic Test Could Reduce Lymph Node Biopsy Surgery in Melanoma Patients

Accurately determining whether melanoma has spread to the lymph nodes is crucial for guiding treatment decisions, yet the standard procedure—sentinel lymph node biopsy—remains invasive, costly, and unnecessary... Read more

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.